Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Stuart Bennett.

Newcastle AuthorsTitleYearFull text
Professor Simon Pearce
Dr Anna Mitchell
Dr Stuart Bennett
Professor John Isaacs
Dr Bijayeswar Vaidya
et al.
Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease2012
Professor Mark Walker
Dr Muthu Jayapaul
Dr Stuart Bennett
Erratum: Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (Diabetologia http://dx.doi.org/10.1007/s00125-005-0004-7)2006
Professor Mark Walker
Dr Muthu Jayapaul
Dr Stuart Bennett
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (vol 49, pg 1131, 2006)2006
Dr Ibrahim Ibrahim
Dr Ee Lim
Dr Salman Razvi
Professor Simon Pearce
Dr Stuart Bennett
et al.
Langerhans cell histiocytosis: management dilemma for the adult endocrinologist2006
Professor Mark Walker
Dr Muthu Jayapaul
Dr Stuart Bennett
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects2005
Dr Carmela Ciardullo
Dr Stuart Bennett
Professor Mark Walker
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: Does it really work? If yes, is it a novelty?2005
Dr Stuart Bennett
Professor Mark Walker
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance2004
Professor Louise Parker
Dr Douglas Lamont
Professor Nigel Unwin
Professor Mark Pearce
Dr Stuart Bennett
et al.
A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years2003
Professor Louise Parker
Dr Douglas Lamont
Professor Nigel Unwin
Professor Mark Pearce
Dr Stuart Bennett
et al.
A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years.[Erratum appears in Diabet Med. 2003 Sep;20(9):781]2003
Dr Stuart Bennett
Dr Richard Quinton
Congenital hypopituitarism presenting as adult-onset hypogonadotrophic hypogonadism2002
Dr Stuart Bennett
Professor Mark Walker
Rosiglitazone improves glycaemic and insulinaemic responses in subjects with impaired glucose tolerance2001
Dr Stuart Bennett
Professor Mark Walker
Rosiglitazone improves insulin sensitivity and 24-hour ambulatory blood pressure in subjects with IGT2001
Dr Stuart Bennett
Professor Mark Walker
Physical activity in non-diabetic relatives of type 2 diabetic patients1999
Dr Douglas Lamont
Professor Louise Parker
Dr Stuart Bennett
Professor Nigel Unwin
Emeritus Professor Alan Craft
et al.
Early life and later determinants of adult disease: A 50 year follow-up study of the Newcastle Thousand Families cohort1998